stocksGUJTHEM
GUJTHEM

Gujarat Themis Biosyn Ltd.

369.60-0.5 (-0.14%)
17 Jul, 12:00 AM

Annual Reports and Financial Documents

Gujarat Themis Biosyn Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

Corporate Announcements and Regulatory Filings

Gujarat Themis Biosyn Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  • Credit Rating17 Jul 2026
    Announcement under Regulation 30 (LODR)-Credit Rating
    Intimation of revision in credit rating
  • Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 201117 Jul 2026
    Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
    The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 16, 2026 for Themis Medicare Ltd
  • Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 201117 Jul 2026
    Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
    The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 16, 2026 for Pharmaceutical Business ....
  • Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Reg. 201115 Jul 2026
    Updates on revised Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
    The Exchange has received the updates on revised disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) ....
  • General13 Jul 2026
    Announcement Under Regulation 30 (LODR) - Updates On Arbitration Matter.
    Please refer to our intimation under Regulation 30 (LODR) -Updates on Arbitration matter.
  • Postal Ballot10 Jul 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
    Please refer to the attachment.
  • Postal Ballot10 Jul 2026
    Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
    Please refer to the attachment.
  • Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201810 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Please refer to attached Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018.
  • Postal Ballot10 Jul 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
    Please refer to our Scrutinizer''s Report and Voting Results of Postal Ballot dated 8th July, 2026.
  • Postal Ballot10 Jul 2026
    Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
    Please refer to our Postal Ballot Outcome dated 8th July, 2026
  • Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 20114 Jul 2026
    Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.
    The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on July ....
  • Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 20114 Jul 2026
    Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
    The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 03, 2026 for Pharmaceutical Business ....
  • Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Reg. 20112 Jul 2026
    Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, ....
  • Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 20112 Jul 2026
    Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CTL Trusteeship Ltd
  • Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 20111 Jul 2026
    Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sachin D Patel
  • Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 20111 Jul 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sachin D Patel
  • General26 Jun 2026
    Announcement Under Regulation 30 (LODR)-Updates
    Please refer to the attachment.
  • Closure of Trading Window25 Jun 2026
    Closure of Trading Window
    Intimation of closure of Trading Window
  • Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Reg. 201124 Jun 2026
    Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, ....
  • Board Meeting Cancelled17 Jun 2026
    Cancellation of Board Meeting
    The Board Meeting to be held on 19/06/2026 Stands Cancelled.

Frequently Asked Questions

Where can I download the annual report of Gujarat Themis Biosyn Ltd.?
Annual reports of Gujarat Themis Biosyn Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Gujarat Themis Biosyn Ltd.?
Quarterly earnings results and presentations of Gujarat Themis Biosyn Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Gujarat Themis Biosyn Ltd. publish earnings call transcripts?
Earnings call transcripts of Gujarat Themis Biosyn Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Gujarat Themis Biosyn Ltd.?
Investor presentations and annual day presentations of Gujarat Themis Biosyn Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Gujarat Themis Biosyn Ltd.?
Corporate announcements and regulatory filings of Gujarat Themis Biosyn Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Gujarat Themis Biosyn Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Gujarat Themis Biosyn Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Gujarat Themis Biosyn Ltd.?
The ISIN (International Securities Identification Number) of Gujarat Themis Biosyn Ltd. is INE942C01045. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Gujarat Themis Biosyn Ltd. listed?
Gujarat Themis Biosyn Ltd. is listed on NSE and BSE. The NSE symbol is GUJTHEM and the BSE code is -.
Where can I find the shareholding pattern of Gujarat Themis Biosyn Ltd.?
The quarterly shareholding pattern of Gujarat Themis Biosyn Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Gujarat Themis Biosyn Ltd. on Sharpely?
Share price data for Gujarat Themis Biosyn Ltd. is updated as of 17 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.